Agilent Completes Acquisition of BIOVECTRA
September 21, 2024
September 21, 2024
SANTA CLARA, California, Sept. 21 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release on Sept. 20, 2024:
* * *
Pharmaceutical customers will benefit from a broader set of specialized CDMO capabilities
* * *
Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and . . .
* * *
Pharmaceutical customers will benefit from a broader set of specialized CDMO capabilities
* * *
Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and . . .